These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9498446)

  • 1. Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis.
    Camerota AJ; Creasey AA; Patla V; Larkin VA; Fink MP
    J Infect Dis; 1998 Mar; 177(3):668-76. PubMed ID: 9498446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock.
    Matyal R; Vin Y; Delude RL; Lee C; Creasey AA; Fink MP
    Intensive Care Med; 2001 Aug; 27(8):1274-80. PubMed ID: 11511939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
    Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
    J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
    Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
    Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
    Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
    Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
    Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shock.
    Goldfarb RD; Glock D; Johnson K; Creasey AA; Carr C; McCarthy RJ; Matushek M; Akhter I; Trenholme G; Parrillo JE
    Shock; 1998 Oct; 10(4):258-64. PubMed ID: 9788657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis.
    Opal SM; Palardy JE; Parejo NA; Creasey AA
    Crit Care Med; 2001 Jan; 29(1):13-7. PubMed ID: 11176151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia.
    Van Den Boogaard FE; Brands X; Schultz MJ; Levi M; Roelofs JJ; Van 't Veer C; Van Der Poll T
    J Thromb Haemost; 2011 Jan; 9(1):122-32. PubMed ID: 21029363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury.
    van den Boogaard FE; Hofstra JJ; Brands X; Levi MM; Roelofs JJ; Zaat SA; Van't Veer C; van der Poll T; Schultz MJ
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):91-99. PubMed ID: 27977318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs.
    Oltrona L; Speidel CM; Recchia D; Wickline SA; Eisenberg PR; Abendschein DR
    Circulation; 1997 Jul; 96(2):646-52. PubMed ID: 9244238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin improves survival in gram-negative sepsis.
    Short BL; Gardiner M; Walker RI; Jones SR; Fletcher JR
    Adv Shock Res; 1981; 6():27-36. PubMed ID: 6760707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
    Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.
    Elsayed YA; Nakagawa K; Kamikubo YI; Enjyoji KI; Kato H; Sueishi K
    Am J Clin Pathol; 1996 Nov; 106(5):574-83. PubMed ID: 8929465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
    Nelson D; Kuppermann N; Fleisher GR; Hammer BK; Thompson CM; Garcia CT; Novitsky TJ; Parsonnet J; Onderdonk A; Siber GR
    Crit Care Med; 1995 Jan; 23(1):92-8. PubMed ID: 8001394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
    Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
    Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
    Aagaard S; Hjortdal VE; Barker JH
    APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia.
    van den Boogaard FE; Hofstra JJ; van 't Veer C; Levi MM; Roelofs JJ; van der Poll T; Schultz MJ
    PLoS One; 2015; 10(5):e0127261. PubMed ID: 25992779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.